Tandem Diabetes Care | TNDM - Debt


Tandem Diabetes Care reported $449.28M in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
Abbott USD 12.94B 496M Sep/2025
Accuray USD 170.24M 4.52M Sep/2024
Align Technology USD 121.27M 1.75M Sep/2025
AtriCure USD 76.73M 521K Sep/2025
Baxter International USD 9.71B 13M Sep/2025
Becton, Dickinson and Co. USD 19.54B 358M Dec/2025
Boston Scientific USD 12.05B 19M Sep/2025
Cooper Companies USD 2.51B 27M Sep/2025
Dexcom USD 1.24B 1.21B Dec/2025
Edwards Lifesciences USD 700.3M 2.3M Sep/2025
Eli Lilly USD 42.51B 2.6B Sep/2025
Globus Medical USD 119.34M 1.76M Sep/2025
ICU Medical USD 1.28B 79.88M Dec/2025
Inogen USD 0 0 Jun/2022
Insulet USD 1.01B 384.9M Sep/2025
Integra LifeSciences USD 2.01B 7.91M Sep/2025
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 45.8B 4.97B Sep/2025
Masimo USD 586.2M 56M Sep/2025
Medtronic USD 28.07B 1.03B Dec/2025
Merit Medical Systems USD 821.15M 599K Sep/2025
Orthofix International USD 137.23M 338K Sep/2024
Roche Holding CHF 33.03B 1.41B Jun/2025
Stryker USD 14.86B 1.74B Dec/2025
Tandem Diabetes Care USD 449.28M 276K Sep/2025
Teleflex USD 2.77B 774M Sep/2025
Zimmer Biomet Holdings USD 7.52B 593.5M Dec/2025